Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
281
NCT03322137
Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 10, 2017
Completion: Oct 22, 2018
NCT03448081
Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene
Start: Feb 12, 2018
Completion: Dec 10, 2018